GLIPR1L2 Antibodies

Santa Cruz Biotechnology features a diverse variety of GLIPR1L2 monoclonal antibodies for research applications. GLIPR1L2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GLIPR1L2, or GLI Pathway Inhibitor 1 Like 2, plays a crucial role in regulating the Hedgehog signaling pathway, which is essential for cell growth, differentiation, and tissue patterning. Dysregulation of GLIPR1L2 has been implicated in various cancers and developmental disorders, making it a significant target for therapeutic research. Understanding GLIPR1L2 function can provide insights into tumor biology and potential treatment strategies. Researchers worldwide utilize GLIPR1L2 monoclonal antibodies to investigate cellular pathways and disease mechanisms. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization of GLIPR1L2 in experimental settings. Santa Cruz Biotechnology monoclonal antibodies for GLIPR1L2 support researchers in advancing scientific understanding of disease mechanisms and potential therapeutic approaches.